Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$5.16 - $11.95 $170,522 - $394,911
-33,047 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$6.57 - $12.0 $4,447 - $8,124
-677 Reduced 2.01%
33,047 $217,000
Q4 2021

Feb 08, 2022

SELL
$10.73 - $23.74 $26,503 - $58,637
-2,470 Reduced 6.82%
33,724 $362,000
Q3 2021

Nov 15, 2021

SELL
$13.65 - $22.4 $115,206 - $189,056
-8,440 Reduced 18.91%
36,194 $735,000
Q2 2021

Aug 13, 2021

BUY
$20.96 - $42.81 $935,528 - $1.91 Million
44,634 New
44,634 $935,000

Others Institutions Holding PRTG

About PORTAGE BIOTECH INC.


  • Ticker PRTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,943,700
  • Market Cap $68.5M
  • Description
  • Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...
More about PRTG
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.